MARASKA dioničko društvo za proizvodnju i promet alkoholnih i bezalkoholnih pića financials
MARASKA dioničko društvo za proizvodnju i promet alkoholnih i bezalkoholnih pića
74780000Y0VHST8OEI02 | Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | HRK 128.7M | HRK 107.9M |
| Other income | HRK 3.8M | HRK 2.4M |
| Operating expenses | HRK 130.9M | HRK 108.5M |
| Employee benefits expense | HRK 17.8M | HRK 15.9M |
| Raw materials & consumables used | HRK 80.3M | HRK 58.1M |
| Depreciation & amortisation | HRK 10.5M | HRK 9.6M |
| Operating profit (EBIT) | HRK 1.7M | HRK 1.8M |
| Net finance income / (cost) | -HRK 1.1M | -HRK 1.7M |
| Finance costs | HRK 2.1M | HRK 2.5M |
| Profit before tax | HRK 576.0K | HRK 67.0K |
| Income tax expense | HRK 328.0K | HRK 1.6M |
| Profit for the year | HRK 249.0K | -HRK 1.5M |
| Total comprehensive income | HRK 249.0K | -HRK 1.5M |
| Cash flow statement | ||
| Cash generated from operations | HRK 5.1M | HRK 13.7M |
| Net cash from operating activities | HRK 3.1M | HRK 12.4M |
| Net cash from investing activities | -HRK 256.0K | -HRK 699.0K |
| Purchase of intangibles | HRK 223.0K | HRK 223.0K |
| Net cash from financing activities | -HRK 5.4M | -HRK 8.0M |
| Proceeds from borrowings | HRK 37.0M | HRK 5.0M |
| Repayments of borrowings | HRK 40.1M | HRK 10.7M |
| Lease liability payments | HRK 2.4M | HRK 2.3M |
| Balance sheet | ||
| Total assets | HRK 159.1M | HRK 154.4M |
| Non-current assets | HRK 82.5M | HRK 91.0M |
| Property, plant & equipment | HRK 81.2M | HRK 89.3M |
| Current assets | HRK 76.6M | HRK 63.5M |
| Inventories | HRK 28.3M | HRK 25.2M |
| Trade & other receivables | HRK 44.7M | HRK 31.1M |
| Cash & equivalents | HRK 332.0K | HRK 3.0M |
| Total equity | HRK 43.3M | HRK 43.0M |
| Non-current liabilities | HRK 48.1M | HRK 45.7M |
| Long-term borrowings | HRK 47.5M | HRK 44.7M |
| Current liabilities | HRK 67.7M | HRK 65.8M |
| Derived metrics | ||
| Free cash flow | HRK 2.9M | HRK 11.9M |
| Operating margin | 1.3% | 1.7% |
| Net margin | 0.2% | -1.4% |
| Return on equity | 0.6% | -3.6% |
| Cash conversion ratio | 12.29× | -8.01× |
| Capex coverage | 16.54× | 25.87× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | HRK 3.8M | -HRK 4.7M |
| Adjustments For Decrease Increase In Other Current Assets | -HRK 842.0K | HRK 2.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | HRK 14.3M | HRK 6.1M |
| Adjustments For Depreciation and Amortisation Expense | HRK 10.5M | HRK 9.6M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | HRK 728.0K | HRK 289.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | HRK 724.0K | -HRK 101.0K |
| Adjustments For Income Tax Expense | HRK 328.0K | HRK 1.6M |
| Adjustments For Increase Decrease In Other Current Liabilities | -HRK 8.6M | -HRK 5.5M |
| Adjustments For Interest Expense | HRK 1.7M | HRK 1.5M |
| Adjustments For Interest Income | HRK 57.0K | HRK 3.0K |
| Adjustments For Provisions | -HRK 320.0K | HRK 163.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | HRK 3.0K | HRK 174.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | HRK 13.8M | HRK 11.6M |
| Changes In Inventories of Finished Goods and Work In Progress | -HRK 6.2M | HRK 3.4M |
| Current Biological Assets | HRK 3.0M | HRK 3.9M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | HRK 30.2M | HRK 35.4M |
| Deferred Tax Assets | HRK 1.1M | HRK 1.4M |
| Equity and Liabilities | HRK 159.1M | HRK 154.4M |
| Finance Income | HRK 985.0K | HRK 739.0K |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | HRK 724.0K | -HRK 101.0K |
| Increase Decrease In Cash and Cash Equivalents | -HRK 2.6M | HRK 3.7M |
| Increase Decrease In Working Capital | -HRK 8.7M | HRK 2.1M |
| Intangible Assets Other Than Goodwill | HRK 112.0K | HRK 195.0K |
| Interest Paid Classified As Operating Activities | HRK 2.1M | HRK 1.3M |
| Interest Received Classified As Investing Activities | HRK 57.0K | HRK 3.0K |
| Issued Capital | HRK 99.9M | HRK 99.9M |
| Noncurrent Financial Assets | HRK 22.0K | HRK 22.0K |
| Noncurrent Provisions | HRK 637.0K | HRK 957.0K |
| Other Adjustments For Noncash Items | -HRK 46.0K | -HRK 24.0K |
| Other Comprehensive Income | HRK 0 | HRK 0 |
| Other Current Assets | HRK 339.0K | HRK 299.0K |
| Other Current Payables | HRK 13.5M | HRK 7.6M |
| Other Expense By Nature | HRK 27.7M | HRK 21.6M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | HRK 95.0K | HRK 0 |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | HRK 185.0K | HRK 479.0K |
| Retained Earnings | -HRK 56.9M | -HRK 55.3M |
| Revenue and Operating Income | HRK 132.5M | HRK 110.3M |
| Trade and Other Current Payables To Trade Suppliers | HRK 24.1M | HRK 22.8M |
Every line item above is a fact tagged in MARASKA dioničko društvo za proizvodnju i promet alkoholnih i bezalkoholnih pića's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (HRK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.